Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.
about
PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancerHomoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.Reduced CaM/FLIP binding by a single point mutation in c-FLIP(L) modulates Fas-mediated apoptosis and decreases tumorigenesis.Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells.
P2860
Q33731141-59C6FD7F-3E0B-4CE4-AE01-F4F190DC9334Q37028411-57AB0177-D2AE-4203-82C0-510D78E0CD8AQ38839654-64FB4FCD-9B43-41BC-AF51-8B235B33E06DQ38880884-2266BA18-3FBE-45D9-BADF-D29C7950CEB2Q39474971-EC83D166-6B92-486A-8318-504E8BE49867Q41065670-818B8A34-A961-45C2-94A3-B28A0D16F400Q55387968-B888D1D4-F52F-44D2-9682-89F5DD3D4EC8
P2860
Tamoxifen enhances therapeutic effects of gemcitabine on cholangiocarcinoma tumorigenesis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tamoxifen enhances therapeutic ...... langiocarcinoma tumorigenesis.
@en
Tamoxifen enhances therapeutic ...... langiocarcinoma tumorigenesis.
@nl
type
label
Tamoxifen enhances therapeutic ...... langiocarcinoma tumorigenesis.
@en
Tamoxifen enhances therapeutic ...... langiocarcinoma tumorigenesis.
@nl
prefLabel
Tamoxifen enhances therapeutic ...... langiocarcinoma tumorigenesis.
@en
Tamoxifen enhances therapeutic ...... langiocarcinoma tumorigenesis.
@nl
P2093
P2860
P1476
Tamoxifen enhances therapeutic ...... langiocarcinoma tumorigenesis.
@en
P2093
Amy N Turk
Jay M McDonald
Juan P Arnoletti
Kaiyu Yuan
Nirag C Jhala
Yabing Chen
P2860
P2888
P304
P356
10.1038/LABINVEST.2011.60
P577
2011-04-04T00:00:00Z